Does Virtual Reality Affect Children's Dental Anxiety, Pain, And Behaviour? A Randomised, Placebo-Controlled, Cross-Over Trial

被引:12
|
作者
Buldur, Burak [1 ]
Candan, Merve [1 ]
机构
[1] Sivas Cumhuriyet Univ, Fac Dentist, Dept Pediat Dent, TR-58140 Sivas, Turkey
关键词
Behavior Observation Techniques; Dental Anxiety; Toothache; Virtual Reality; AUDIOVISUAL DISTRACTION; EXPOSURE THERAPY; EFFICACY; EYEGLASSES; ANALGESIA; PHOBIA;
D O I
10.1590/pboci.2021.002
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: To evaluate the effect of virtual reality (VR) on dental anxiety, pain, and behaviour at different time points among children undergoing dental treatment under local anaesthesia. Material and Methods: This randomised, two-armed, within-subject, cross-over, placebo-controlled trial included 76 children. Eligible participants were treated in two dental visits using the following methods: with protective glasses only, without distraction (attention placebo-controlled - APC); and with the treatment condition (i.e., VR). Primary outcomes were dental anxiety and pain; secondary outcome was dental visit behaviour. Heart rate scores were recorded as an objective measure to evaluate dental anxiety and pain. Subjective measurements for each variable were also performed. Results: Significant reduction in dental pain and anxiety was observed in the VR group, according to the heart rate scores; however, no statistical differences were observed according to the self-reported measures. Decreased dental anxiety and pain were associated with the first visit sequence with VR. Dental pain and anxiety scores were lower during local anaesthesia in the VR group than in the APC group. Conclusion: Virtual reality significantly reduced pain and anxiety during local anaesthesia in children undergoing dental treatment; therefore, it may be recommended during dental treatment in school-age children.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [11] Behaviour and Anxiety Management of Paediatric Dental Patients through Virtual Reality: A Randomised Clinical Trial
    Gomez-Polo, Cristina
    Vilches, Ana-Aida
    Ribas, David
    Castano-Seiquer, Antonio
    Montero, Javier
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [12] Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN® in patients with Sickle Cell Disorder
    Wambebe, C
    Khamofu, H
    Momoh, JAF
    Ekpeyong, M
    Audu, BS
    Njoku, OS
    Bamgboye, EA
    Nasipuri, RN
    Kunle, OO
    Okogun, JI
    Enwerem, MN
    Audam, JG
    Gamaniel, KS
    Obodozie, OO
    Samuel, B
    Fojule, G
    Ogunyale, O
    PHYTOMEDICINE, 2001, 8 (04) : 252 - 261
  • [13] SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial
    Rossi, Megan
    Johnson, David W.
    Morrison, Mark
    Pascoe, Elaine
    Coombes, Jeff S.
    Forbes, Josephine M.
    McWhinney, Brett C.
    Ungerer, Jacobus P. J.
    Dimeski, Goce
    Campbell, Katrina L.
    BMC NEPHROLOGY, 2014, 15
  • [14] SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial
    Megan Rossi
    David W Johnson
    Mark Morrison
    Elaine Pascoe
    Jeff S Coombes
    Josephine M Forbes
    Brett C McWhinney
    Jacobus PJ Ungerer
    Goce Dimeski
    Katrina L Campbell
    BMC Nephrology, 15
  • [15] Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomised, double-blind, cross-over trial
    Bruijn, Jacques
    Duivenvoorden, Hugo
    Passchier, Jan
    Locher, Heiko
    Dijkstra, Natascha
    Arts, Willem-Frans
    CEPHALALGIA, 2010, 30 (12) : 1426 - 1434
  • [16] Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial
    Karsten, Julie
    Hagenauw, Loes A.
    Kamphuis, Jeanine
    Lancel, Marike
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (03) : 327 - 337
  • [17] Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
    Israel, E
    Chinchilli, VM
    Ford, JG
    Boushey, HA
    Cherniack, R
    Craig, TJ
    Deykin, A
    Fagan, JK
    Fahy, JV
    Fish, J
    Kraft, M
    Kunselman, SJ
    Lazarus, SC
    Lemanske, RF
    Liggett, SB
    Martin, RJ
    Mitra, N
    Peters, SP
    Silverman, E
    Sorkness, C
    Szefler, SJ
    Wechsler, ME
    Weiss, ST
    Drazen, JM
    LANCET, 2004, 364 (9444): : 1505 - 1512
  • [18] Motor excitability and motor behaviour after modafinil ingestion - a double-blind placebo-controlled cross-over trial
    Liepert, J
    Allstadt-Schmitz, J
    Weiller, C
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (06) : 703 - 711
  • [19] Motor excitability and motor behaviour after modafinil ingestion – a double-blind placebo-controlled cross-over trial
    J. Liepert
    J. Allstadt-Schmitz
    C. Weiller
    Journal of Neural Transmission, 2004, 111 : 703 - 711
  • [20] Simvastatin Treatment Does Not Affect Serum Vitamin D Concentrations in Patients with Dyslipidemia: A Randomized Double-blind Placebo-controlled Cross-over Trial
    Mazidi, Mohsen
    Rokni, Haleh
    Sahebkar, Amir Hossein
    Mohammadi, Akram
    Ghayour-Mobarhan, Majid
    Ferns, Gordon A.
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2016, 7